The Incidence of Pharyngeal Cancer in the Republic of Azerbaijan for 2019–2022

Anar Mammadov 1 *
More Detail
1 Outpatient Chemotherapy Department II, National Center of Oncology of the Ministry of Health of the Republic of Azerbaijan, Baku, Azerbaijan
* Corresponding Author
J CLIN MED KAZ, In press. https://doi.org/10.23950/jcmk/15927
OPEN ACCESS 46 Views 0 Downloads
Author Contributions: The author contributed to all aspects of the paper: literature search, data curation, analysis, interpretation, writing, editing. The author has read and agreed to the published version of the manuscript.

ABSTRACT

Introduction: Pharyngeal cancer is a rapidly progressing disease that leads to disability. Epidemiological studies are one of the components of the anti-cancer measures. Knowledge of the territorial prevalence of tumors allows us to solve the issues of their prevention and early detection.
The aim of the present study was Epidemiological analysis of the incidence of pharyngeal cancer in the Republic of Azerbaijan.
Methodology: The analysis of the epidemiological situation was carried out using incidence rate, attack rate and age-standardized rate per 100.000 population from 2019 to 2022 in the Republic of Azerbaijan
Results: The incidence rates of pharyngeal cancer in the Republic of Azerbaijan for the period 2019–2022 were varied in the range 1,0–1,2 (men) and 0,5–0,7 (women) . A similar case was observed in attack rates which were 4,9 -5,7 in males, 3,2- 3,5 in females. The highest values of the standardized rates of the incidence of pharyngeal cancer were observed in the age group of 50–59 years and 60–69 years for both sex.
Conclusion: The incidence of pharyngeal cancer remained stable over the study period. The incidence of this form of cancer was relatively higher among men than among women.
Keywords: pharyngeal cancer, morbidity, intensity, attack rate, age-standardized indicator.

CITATION

Mammadov A. The Incidence of Pharyngeal Cancer in the Republic of Azerbaijan for 2019–2022. J Clin Med Kaz. 2025. https://doi.org/10.23950/jcmk/15927

REFERENCES

  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3): 209–249. https://doi.org/10.3322/caac.21660.
  • Zumsteg ZS, Luu M, Rosenberg PS, Elrod JK, Bray F, Vaccarella S, Gay C, Lu DJ, Chen MM, Chaturvedi AK, Goodman MT. Global epidemiologic patterns of oropharyngeal cancer incidence trends. Journal Natl Cancer Inst. 2023; 115(12): 1544–1554. https://doi.org/10.1093/jnci/djad169.
  • de Souza DLB, de Camargo Cancela M, Pérez MMB, Curado M-P. Trends in the incidence of oral cavity and oropharyngeal cancers in Spain. Head Neck. 2012; 34(5): 649–654. https://doi.org/10.1002/hed.21793.
  • Sedrak M, Rizzolo D. Understanding the link between HPV and oropharyngeal cancer. JAAPA. 2009; 22: 42–46. https://doi.org/10.1097/01720610-200910000-00009.
  • Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML. Human papilloma virus and rising oropharyngeal cancer in the United States. J Clin Oncol. 2011; 29: 4294–4294. https://doi.org/10.1200/JCO.2011.36.4596.
  • de Camargo Cancela M, de Souza DL, Curado MP. International incidence of oropharyngeal cancer: A population-based study. Oral Oncol. 2012; 48(6): 484–490. https://doi.org/10.1016/j.oraloncology.2011.12.013.
  • Bosetti C, Negri E, Franceschi S, Conti E, Levi F, Tomei F, La Vecchia C. Risk factors for oral and pharyngeal cancer in women: a study from Italy and Switzerland. Br J Cancer. 2000; 82(1): 204–207. https://doi.org/10.1054/bjoc.1999.0900.
  • De Stefani E, Boffetta P, Deneo-Pellegrini H, Ronco AL, Acosta G, Ferro G, Oreggia F, Leiva J. The effect of smoking and drinking in oral and pharyngeal cancers: a case-control study in Uruguay. Cancer Lett. 2007; 246(1–2): 282–289. https://doi.org/10.1016/j.canlet.2006.03.008.
  • Gallus S, Bosetti C, Franceschi S, Levi F, Simonato L, Negri E, La Vecchia C. Oesophageal cancer in women: tobacco, alcohol, nutritional and hormonal factors. Br J Cancer. 2001; 85(3): 341–345. https://doi.org/10.1054/bjoc.2001.1898.
  • Lucenteforte E, Garavello W, Bosetti C, La Vecchia C. Dietary factors and oral and pharyngeal cancer risk. Oral Oncol. 2009; 45(6): 461–467. https://doi.org/10.1016/j.oraloncology.2008.09.002.
  • Sedrak M, Rizzolo D. Understanding the link between HPV and oropharyngeal cancer. JAAPA. 2009; 22(10): 42–46. https://doi.org/10.1097/01720610-200910000-00009.
  • Patini R, Cordaro M, Marchesini D, Scilla F, Gioco G, Rupe C, D'Agostino MA, Lajolo C. Is Systemic Immunosuppression a Risk Factor for Oral Cancer? A Systematic Review and Meta-Analysis. Cancers (Basel). 2023; 15(12): https://doi.org/10.3390/cancers15123077.